The
2003 annual scientific meeting was the largest meeting held by
the SSA. The attendance was in excess of 260 delegates, and pushed
the venue to its limits. Alastair Corbett (Chair of the Conference
Committee) and Chris Levi (chair of the Program committee) and
their respective committees did a wonderful job to ensure a stimulating
meeting.
a.
Peter Bladin New Investigator Award
The
SSA Peter Bladin Award was awarded to Anne Abbott for her paper
entitled “Embolic Signal Detection and Prediction of Ipsilateral
Ischaemic Symptoms in Patients with High-Grade Asymptomatic Carotid
Stenosis”.
b.
National Stroke Foundation New Investigator Award
The
National Stroke Foundation New Investigator Award was awarded
to Jim Jannes for his paper entitled “Tissue Plasminogen
Activator –7351c/T Enhancer Polymorphism is a Risk Factor
for Lacunar Stroke”.
c.
Publication of Abstracts
The
abstracts of the Sydney meeting are due to be published in the
Internal Medical Journal February 2004. Please note that the abstracts
are not necessarily in the same order that they were in the meeting
program.
In
2003 applications were invited for the inaugural Overseas Study
Scholarship and Overseas Travel Fellowship. There were no applications
for the Overseas Travel Fellowships, and instead two awards were
made for the Overseas Study Scholarships because of the high quality
of the applications. The awardees were Maree Hackett and Julie
Bernhardt. Their reports are provided below.
• Stroke
Society of Australasia Overseas Study Experience (Maree Hackett)
This
year, the Stroke Society of Australasia kindly awarded me with
one of two available 'overseas study scholarships'. On my application
I had requested assistance with travel to Leeds and Edinburgh
Universities to undertake some focused work on three Cochrane
Reviews of treatment and prevention strategies for mood disorders
following stroke. The protocols for these reviews are available
on the Cochrane website (http://www.update-software.com/cochrane/).
On
the 18th of May I left Auckland, heading for Valencia, Spain.
Fortunately for me, the slight delay in the assessment of scholarship
applications provided the perfect opportunity to attend the European
Stroke Conference (ESC) at the beginning of my mini-sabbatical.
The ESC was most entertaining, with New Zealand and Australian
researchers having a high profile in the presentations. I gave
a platform presentation on the preliminary results of the third
Auckland Regional Community Stroke Study and the feedback was
positive. The full results are planned for release in 2004.
It
was then a short journey across a different ditch to spend two
and a half weeks with Professor Allan House and colleagues at
the Academic Unit of Psychiatry, The University of Leeds and two
weeks with Professor Peter Sandercock and colleagues at the Department
of Clinical Neurosciences, The University of Edinburgh.
The
opportunity to spend dedicated time on the Reviews was fantastic,
and without the SSA's assistance, something that would have alluded
me. During my time in Leeds I discussed the emotionalism review
at length with my co-author Professor Allan House, and become
familiar with the areas of concern specific to abnormal mood following
stroke. I completed entry of all available data into the review-specific
software for all three reviews (interventions for emotionalism,
treatment of depression and prevention of depression following
stroke) and gained valuable assistance and advice from the Cochrane
Schizophrenia Editorial group who are based at Leeds. This also
provided me with the opportunity to see first-hand how other review
groups work. I met with staff running the post-stroke observational
study and randomised controlled trial at Leeds, and provided guidance
to two psychiatric registrars who are planning research in the
area of abnormal mood following stroke.
In
Edinburgh I spent time with the staff of the Cochrane Stroke Editorial
group. This included meeting with their statistician (Steph Lewis)
to discuss appropriate analysis and presentation of data for all
three reviews. I also had several meetings with Professor Peter
Sandercock to discuss the content and text flow of each review
and I attended the weekly stroke research seminars. The remainder
of my time in Edinburgh was dedicated to writing the text for
the reviews. I returned to Leeds for half a week to finalise the
Emotionalism review and outline roles and responsibilities for
ongoing work after my return to New Zealand.
It
is with great pleasure that I inform you that all three reviews
have since been submitted to the Cochrane Stroke Group editorial
base in Edinburgh. I also submitted a related abstract for presentation
at last years SSA conference. And it was most interesting to note
that Cochrane Editorial groups seem to be housed in the basement
of their respective universities.
I
would like to thank the SSA once again for supporting a young
researcher. The scholarship provided a wonderful opportunity for
me to meet with colleagues from around the world with similar
research interests and vastly increased my knowledge of Cochrane
methodology and mood disorders following stroke. I should also
mention that Valencia, Leeds, Edinburgh and the surrounding countryside
are very picturesque and I embraced the opportunity to look around
and sample the fine cuisine and available beverages.
Maree
Hackett
Research Fellow
Clinical Trials Research Unit
The University of Auckland, New Zealand
• Stroke
Society of Australasia Overseas Study Scholarship (Julie Bernhardt)
In
2003 I was awarded a SSA Overseas Study Scholarship. My goals
for this scholarship were:
- to
have face to face meetings with international collaborators,
Prof Peter Langhorne (Glasgow) and Prof Bent Indredavik (Trondheim,
Norway), both of whom had expressed an interest in the development
of a randomised controlled trial of very early rehabilitation
(AVERT);
- undertake
a period of training in the very early mobilisation programme
employed in the Trondheim stroke unit (and regarded as a very
promising though untested rehabilitation method), and
- acquire
detailed data, using behavioural mapping techniques, about
activity levels of patients managed on a ward that practices
very early mobilisation. These data could then be compared
to data we acquired in Phase 1 of AVERT from patients managed
in 5 Melbourne stroke units (Publication in press).
All
three goals were achieved on this study visit. I was handed a
uniform on my arrival in Trondheim and spent several weeks engaged
in the practice of very early mobilisation. The Trondheim staff
were very welcoming and I was able to witness and be a part of
what I believe is a unique model of stroke patient care. Together
with collaborators we have since formalised the Phase 2 protocol
for AVERT (safety and feasibility study) which commenced at Austin
Health in February 2004. Planning for the Phase 3 multi-centre
trial is underway. Finally, the activity data acquired in Trondheim
were contrasted with data from Melbourne and presented at the
2003 SSA meeting. As further data are acquired we will submit
the comparison for publication.
The
SSA scholarship enabled me to undertake a wonderful study experience
in the UK and Norway that has allowed me to progress my post doctoral
research more quickly, and with a broader international focus,
than would otherwise have been the case. I can’t thank them
enough!
Julie
Bernhardt
Senior Research Fellow
National Stroke Research Institute
Melbourne, Australia